Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation

Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution

NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy

Cancer-associated fibroblast–secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas

Prohibitin Expression in Antigen-Presenting Cells: Implications for Inciting Trigger in CNS IgG4-Related Disease

Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma

Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas

Fully Automated Sequential Immunofluorescence (seqIF) for Hyperplex Spatial Proteomics

Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma

Immune Spatial Differences Between Short and Long-term Surviving Glioblastoma Patients

Immune Spatial Differences Between Short and Long-term Surviving Glioblastoma Patients